Meral Mert^*, Refik Tanakol, Hande Karpuzoglu, Semra Abbasoglu, Sema Yarman, Harika Boztepe, Faruk Alagol

Show more
Istanbul University, Istanbul Medical Faculty, Department of Internal Medicine, Division of Endocrinology and Metabolism, Istanbul, Turkey.
Istanbul University, Istanbul Medical Faculty, Department of Biochemistry, Istanbul, Turkey.
Show less

Abstract: Background: Diagnosis of Cushing’s Syndrome (CS) at the right time and with the right method is getting more important for the patients and clinicians due to high mortality rate. The most appropriate laboratory test will provide great benefits in terms of cost-effectiveness in the well-chosen group of patients. Selection of the high risk group is of crucial importance for the true diagnosis and treatment on time. Aim: The aim of this study was to evaluate the worth of the midnight salivary cortisol and to establish other effective factors in the graduation of clinical suspect of CS. Material and Methods: 115 patients were evaluated in weight, height, body mass index (BMI), waist/hip ratio, systolic, diastolic blood pressures, hirsutism, weight gain, purple-stria, plethore, buffalo-hump, supraclavicular fullness, temporal fat cushion, acnea, moonface, proximal muscle weakness, lower limb edema, ecchymosis, loss of libido, depression, diabetes mellitus, hypertension, allopecia of all patients were noted in the evaluation forms (23 findings). Patients were grouped according to clinical scores, low (<8), medium (8 - 16) and high (>16). Results: When we compare the groups in terms of midnight salivary cortisol, morning salivary cortisol after overnight dexamethasone suppression test, we found statistically significant relationship between the low and high clinical score groups, as well as between medium and high score groups (p: 0.0001). Urinary free cortisol was statistically significant only between low and high clinical score groups (p: 0.0001). Conclusion: This clinical scoring system which includes clinical signs and laboratory findings both, can be used for selection of the high risk group.

Keywords: Salivary Cortsiol; Clinical Suspect; Clinical Score; Cushing’s Syndrome

Cite this paper: M. Mert, R. Tanakol, H. Karpuzoglu, S. Abbasoglu, S. Yarman, H. Boztepe and F. Alagol, "Midnight Salivary Cortisol and Other Effective Factors in the Graduation of Clinical Suspect of Cushing Syndrome: Is There Any Reasonable Clinical Score?," Open Journal of Endocrine and Metabolic Diseases, Vol. 3 No. 1, 2013, pp. 52-54. doi: 10.4236/ojemd.2013.31008.

References

[1]   C. M. Plotz, A. I. Knowlton and C. Ragan, “The Natural History of Cushing’s Syndrome,” The American Journal of Medicine, Vol. 13, No. 5, 1952, pp. 597-614. doi:10.1016/0002-9343(52)90027-2

[2]   J. Lindholm , S. Juul , J. O. J?rgensen, et al., “ Incidence and Late Prognosis of Cushing’s Syndrome: A Population-Based Study,” The Journal of Clinical Endocrinology & Metabolism, Vol. 86, No.1, 2001, pp. 117-123.

[3]   G. Leibowitz, A. Tsur and S. D. Chayen, “Preclinical Cushing’s Syndrome: An Unexpected Frequent Cause of Poor Glycemic Control in Obese Diabetic Patients,” Clinical Endocrinology, Vol. 44, No. 6, 1996, pp. 717-722. doi:10.1046/j.1365-2265.1996.737558.x

[4]   James W. Findling and Hershel Raff, “Cushing’s Syndrome: Important Issues in Diagnosis and Management,” The Journal of Clinical Endocrinology & Metabolism, Vol. 91, No. 10, 2006, pp. 3746-3753. doi:10.1210/jc.2006-0997

[5]   J. W. Findling, H. Raff, “Screening and Diagnosis of Cushing’s Syndrome,” Endocrinology and Metabolism Clinics of North America, Vol. 34, No. 2, 2005, pp. 385-402.

[6]   M. Castro, P. C. Elias and A. Quidute, “Out-Patient Screening for Cushing’s Syndrome: The Sensitivity of the Combination of Circadian Rhytm and Overnight Dexamethasone Suppression Salivary Cortisol Tests,” The Journal of Clinical Endocrinology & Metabolism, Vol. 84, No. 3, 1999, pp. 878-882.

[7]   N. Sonino, M. Boscaro, F. Fallo and G. A. Fava, “A Clinical ?ndex for Rating Severity in Cushing’s Syndrome,” Psychother, Vol. 69, No. 4, 2000, pp. 216-220.

[8]   E. J. Ross and C. Linch, “Cushing’s Syndrome-Killing Disease: Discriminatory Value of Signs and Symptoms Aiding Early Diagnosis,” The Lancet, Vol. 18, No. 9, 1982, pp. 646-649.